NewsRoom Articles - Page 87 of 112 - CanadianCannabisWire

WednesdayNov 07, 2018 12:31 pm

Plus Products Inc. (CSE: PLUS) is “One to Watch”

California consumers purchased $180 million worth of cannabis-infused food and drinks in 2017 – 10% of the state’s total marijuana sales – with that percentage rising to 18% in February 2018. Cannabis-infused gummies have a much wider appeal since they are less conspicuous to consume and provide a smoke-free experience Advances in technology allow manufacturers of cannabis-infused edibles to tweak concentrations of THC and CBD The Specialty Food Association has named cannabis edibles as one of the Top 10 food trends of 2018 Plus Products Inc. (CSE: PLUS) is a branded cannabis-infused products manufacturer of edibles created to support a…

TuesdayNov 06, 2018 10:49 am

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) is “One to Watch”

Canada’s only licensed cannabis producer principally focused on premium brands and products with coast-to-coast distribution Current annual production run rate of 13,333 kg, ramping up to estimated 50,000 kg full capacity in 2019 Recently signed 1-year CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY) to support medical cannabis patients Commands premium wholesale prices up to one-third higher than other brands Supply agreements in place with six Canadian provinces Recently uplisted to OTCQX market in the U.S under ticker symbol SPRWF In September 2018 announced record fiscal year and Q4 results Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA:…

FridayNov 02, 2018 11:31 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focusing on its New Subsidiaries and Intellectual Property

Lexaria has its patented DehydraTECH drug delivery platform The company’s technology is a complementary layer that works with the other research being done on cannabinoids Lexaria has a robust IP portfolio and four new subsidiary companies A drug delivery platform pioneer, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its DehydraTECH technology. The company’s technology changes the way in which edible cannabinoids absorb into the body. The DehydraTECH drug delivery platform is patented for cannabidiol and all other non-psychoactive cannabinoids and enables the transportation of bioactive substances via oral ingestion. A research-driven enterprise, Lexaria Bioscience is based…

ThursdayNov 01, 2018 11:42 am

The Flowr Corporation (TSX.V: FLWR) is Coming into Full Bloom

Company fulfilled purchase orders from British Columbia, Nova Scotia and Ontario in-full and on-time for October 17 adult-use market opening and is preparing re-stocking shipments following sell-outs Flowr launched new Ace Valley brand in partnership with the team behind the highly successful Ace Hill Beer Company broke ground on a first-of-its-kind, 50,000 square foot R&D facility funded by its exclusive R&D partner, the Hawthorne Gardening Division of the Scotts Miracle-Gro Company. Facility is expected to open in the summer of 2019 alongside Flowr’s cultivation complex in Kelowna, BC October has been a busy month for Canadian cannabis companies, perhaps none…

WednesdayOct 31, 2018 11:18 am

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Comments on DEA’s Removal of Cannabidiol from Schedule 1

Phivida’s vision is to help lessen the world’s dependence on pharmaceuticals The company comprises two main brands Phivida recently talked about the removal of CBD from Schedule 1 of the Controlled Substances Act Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is a premium functional food and beverage company. Its focus is whole plant nutrition and natural ingredients. As a result, it infuses organic active hemp extract into an array of premium foods, beverages and clinical products. Phivida’s corporate mission is to help reduce the world’s dependence on pharmaceuticals and provide healthy food and beverage choices. Phivida is headquartered in Vancouver,…

MondayOct 29, 2018 1:17 pm

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Advances Expansion Plans through HemPoland Acquisition

The acquisition of HemPoland accelerates opportunities for growth in the European market as part of TGOD’s international strategy The company has received medical sales licensing for its Ancaster, Ontario, facilities – one of many sites where TGOD aims to cultivate cannabis products The company recently closed a $75 million bought deal financing to further its expansion plans in Latin America and Europe Cannabis company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) has announced the acquisition of HemPoland and the closing of a new bought deal financing, part of several recent developments demonstrating the company’s strong commitment to…

WednesdayOct 24, 2018 10:37 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives Two US Patents, Bringing Total to 10 in First Patent Family across US and Australia

The two new patents are related to certain cannabinoid-infused beverage compositions using LXRP’s DehydraTECH technology Globally, LXRP has filed some 50 patent applications as the company expands its IP portfolio; LXRP hopes to receive two more granted patents from Australia by year end, giving it 12 in total LXRP out-licenses its technology, which promotes healthier and faster ingestion; the company seeks accelerated patent application examinations in Australia based on the U.S. patents Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has been granted two new U.S. patents based on cannabinoid-infused beverage compositions using its DehydraTECH ingestion technology platform. The company is…

MondayOct 22, 2018 9:00 am

Canada Leads International Cannabis Boom — and It’s Not About Smoking

CanadianCannabisWire Editorial Coverage: Legal changes in Canada are creating an ideal base for cannabis companies, which are shifting their focus away from smoking. As the first G20 nation to make recreational cannabis legal, Canada is creating an opportunity for its cannabis companies to become global leaders. Analysis shows that the global cannabis market is larger than expected — and set to keep growing. Many new consumers prefer not to smoke their cannabis, leading to a shift towards cannabis-derived food and drinks. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has developed patented technology that helps make cannabis available to…

TuesdayOct 16, 2018 11:28 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Completes Establishment of Four Wholly Owned Subsidiaries

Lexaria’s technology changes the manner in which edible cannabinoids enter the body The company out-licenses its DehydraTECH drug delivery platform Lexaria recently announced the creation of four wholly owned subsidiaries A research-driven company, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is the only company globally that has been awarded a patent for the improved delivery of all cannabinoids. It has developed and out-licenses its DehydraTECH technology – a drug delivery platform. This technology is a complementary layer that works with other research and development being conducted on cannabinoids and, as such, is an enabling technology, not a competing one. Lexaria…

WednesdayOct 10, 2018 12:48 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Infuses Cannabis Industry, Delivers Results with Innovative Drug Delivery Platform

Global legal cannabis market projected to surpass $146 billion by end of 2025 Cannabinoid-infused edibles, concentrates represent fastest-growing segment of industry Lexaria’s patented technology improves bio-absorption and bioavailability of active ingredients while masking unpleasant taste Lucrative licensing business model includes agreements to enhance cannabinoid (CBD) delivery before year-end 2018 Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and its proprietary technology found in the company’s drug delivery platform DehydraTECH has application for several subsets of the cannabis industry and other pharmacological verticals. As a technology proven to deliver increased intestinal absorption rates and higher bioavailability for a number of bioactive compounds,…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977